BJP leads in Maharashtra, NCP blames Chavan

October 19, 2014

Mumbai, Oct 19: The BJP took early leads Sunday in Maharashtra as officials counted millions of votes polled in assembly elections.

BJP ChavanHaving dumped long-time ally Shiv Sena ahead of the election, the Bharatiya Janata Party led in 75 of the 288 seats in the state, followed by the Shiv Sena at a distant 37.

The Congress was leading in 15 seats and its erstwhile ally, the Nationalist Congress Party (NCP), in 19. The Maharashtra Navnirman Sena led in one seat.

Seeing the writing on the wall, the NCP blamed the Congress for the impending rout.

"It all happened because of Chavan," NCP's Nawab Malik told the media, referring to former chief minister Prithviraj Chavan of the Congress.

"He had no understanding of the issues in Maharashtra, he did not take the right decisions, and he didn't act when he had to. He is responsible for the state of both the Congress and the NCP," Malik said.

The NCP and Congress have been in power in Mahrashtra for 15 years. The coalition came apart just before the Oct 15 polls, leading to President's Rule in the state.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 25,2020

New Delhi, Jun 25: After the Drug Controller General of India (DCGI) given its approval to manufacture and market the generic version of COVID-19 drug Remdesivir, COVIFOR, Hyderabad-based drugmaker Hetero Limited has delivered the first set of 20,000 vials in two equal lots of 10,000 each across 5 states.

The first batch, which is being marketed under the brand name of COVIFOR, was delivered to Maharashtra, Delhi, Gujarat Tamil Nadu and Hyderabad. Hetero has set a target to produce one lakh vials of the drug in two-three weeks.

The other lot would be supplied to Kolkata, Indore, Bhopal, Lucknow, Patna, Bhubaneshwar, Ranchi, Vijayawada, Cochin, Trivandrum and Goa within a week to meet the emergency requirements.

Managing director of Hetero Healthcare M Srinivasa Reddy said “the launch of Covifor in the country is a milestone in addressing public health emergencies. Through Covifor, we hope to reduce the treatment time of a patient in a hospital thereby reducing the increasing pressure on the medical infrastructure overburdened ue to accelerating COVID-19 infection rates," he said as reported by news agency.

"We are closely working with the government and the medical community to make Covifor quickly accessible to both public and private healthcare settings across the country”, Reddy said.

Covifor is a generic brand of Remdesivir which is used for the treatment of COVID-19 in adults and children hospitalised with strong symptoms of the disease. The Health Ministry had, on June 13, recommended the use of anti-viral drug Remdesivir in moderate stage of COVID-19.

Dr Reddys Laboratories and Hetero are among others which have separately entered into non-exclusive licensing agreements with the original drug-maker Gilead Sciences Inc to register, make and sell the investigational drug Remdesivir in India and other countries.

Remdesivir would be made in the company's formulation facility in Hyderabad, which has been approved by global regulatory authorities such as US Food and Drug Administration (USFDA) and EU, among others, Hetero had earlier said.

The treatment first showed improvement in trials on coronavirus patients and was approved for emergency use in severely ill patients in the United States and South Korea.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 3,2020

Mumbai, Mar 3: The country will turn "peaceful" if Prime Minister Narendra Modi's "bhakts" follow him in quitting the social media, the NCP said on Tuesday, taking a dig at the PM over his tweet that was thinking of giving up his social media accounts.

NCP chief spokesperson and Maharashtra minister Nawab Malik also said that Modi's decision will be "in the interest of the country".

His comments came a day after Modi said he is contemplating giving up social media presence.

"This Sunday, thinking of giving up my social media accounts on Facebook, Twitter, Instagram & YouTube. Will keep you all posted," the prime minister said on the micro-blogging site.

Taking a swipe at the prime minister, Malik in a tweet said, "Yesterday, Modi ji gave hint of giving up the social media from Sunday. Some leaders are also talking about giving up (the social media). The country will turn peaceful if all the bhakts (followers) give it up."

"Modi ji's decision will be in the interest of the country. We welcome it, Modi ji take decision," Malik tweeted with the hash tag "ModiQuitsSocialMedia".

Earlier, the Congress took a swipe at the prime minister, with Rahul Gandhi tweeting "Give up hatred, not social media accounts" after tagging Modi's post.

Within minutes of Modi's tweet on Monday, scores of netizens urged him not to quit the various social media platforms as 'No Sir' trended on Twitter.

The prime minister is one of the most-followed world leaders on social media. He has 53.3 million followers on Twitter, 44 million on Facebook and 35.2 millionon Instagram.

The Twitter handle of Prime Minister's Office has 32 million followers.

In September 2019, PM Modi was the third most followed world leader on the microblogging site, behind only US President Donald Trump and his predecessor Barack Obama.

The Prime Minister was the first Indian to cross the 50-million followers mark on Twitter.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
June 19,2020

Kota, Jun 19: In a shocking incident, a COVID-19 patient in Rajasthan's Kota district died after his family disconnected the ventilator to plug in the air cooler to combat the scorching heat.

The incident happened on June 15 in the Maharao Bhimsingh Hospital (MBS) hospital.

A committee was formed soon after the death was reported, which will submit its report on Friday at 4 p.m., hospital Medical Superintendent Naveen Saxena told media persons.

He said, "We have set up the committee to investigate the incident based on the primary information. The committee includes deputy superintendent of the hospital, nursing superintendent and CMO. We will look into the matter and then shall explore further action for a need to go to the police."

The family members of the COVID-19 patient, who came to meet him in the MBS hospital unplugged the ventilator and had put on the cooler switch which they had brought from outside. The ventilator worked for some time on the battery but later it collapsed and the patient turned critical.

The doctors were reported of the patient's critical condition who came rushing and did all they could do to save his life, but the result was unfavourable and the patient died.

The doctors were reported of the patient's critical condition who came rushing and did all they could do to save his life, but the result was unfavourable and the patient died.

The relatives, on the other hand, attacked the resident doctors after the patient died.

Doctor Varun, on duty, submitted a written complaint to the officials, alleging that the patients' relatives misbehaved with the staff. Other resident doctors also supported him and boycotted work very briefly, but then later resumed work.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.